Immune response study during pelvic radiation for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies how the immune system responds to pelvic radiation therapy (with or without chemotherapy) in patients with cervical or other gynecologic cancers. It may help explain why some treatments work better and could lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cervical cancer (stage IB2 to IVA) or another gynecologic cancer needing radiation to the pelvis.
- You are able to complete a full course of pelvic radiation, possibly with chemotherapy or brachytherapy (internal radiation).
- You are willing to have extra biopsies and blood draws for research.
- You have not had radiation to the pelvis or chemotherapy for this cancer before.
- You are not on medicines that suppress your immune system or have an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from patients with cervical cancer who are receiving standard treatment with chemotherapy, radiation, and brachytherapy (a type of internal radiation). The goal is to learn more about how this treatment works in a real-world setting to improve care for future patients.
This trial is testing a combination of standard chemotherapy and radiation delivered to the pelvis, followed by an internal radiation treatment guided by CT scans. The goal is to improve treatment for locally advanced cervical cancer while potentially reducing side effects.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
This trial tests a drug called pembrolizumab (an immunotherapy that helps your immune system fight cancer) given along with a special type of radiation therapy (carbon-ion radiotherapy) for advanced cervical cancer. It aims to see if this combination is safe and effective.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
Hear when a new Cervical Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.